logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Toshiaki Tsurui

Showa Medical University
H指数:6
被引数:188

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study

先前局部治疗与系统性治疗方案队列中高级别软组织肉瘤预后的相关性：一项回顾性队列研究

Cancers
IF4.4
2026-08-290
OA
Ryotaro Ohkuma; Tomoyuki Ishiguro; Hirotsugu Ariizumi; Masahiro Shimokawa; Go Ikeda; Takahiro Yoshizawa; Yuya Hirasawa; Risako Suzuki; Toshiaki Tsurui; Emiko Mura; Rika Sasaki; Shuichi Komori; Kosuke Toyofuku; Masako Kato; Kanae Shimada; Shingo Miyamoto; Kouzou Murakami; Yoshihiro Nakagami; Kazuhiko Oshinomi; Yutaro Kubota; Hiroo Ishida; Takeshi Aoki; Masahiko Murakami; Kiyoshi Yoshimura; Satoshi Wada; Katsuhito Takahashi; Takuya Tsunoda; Atsushi Horiike
Association of Intratumoral Macrophage Subsets with Treatment Outcomes in Patients with Stage IV Solid Tumors

肿瘤内巨噬细胞亚群与IV期实体瘤患者治疗结局的关联

Laboratory Investigation
IF4.2
2026-08-120
OAAI
Ryotaro Ohkuma; Nobuyuki Onishi; Aya Misawa; Makoto Watanabe; Jian Jin; Hirotsugu Ariizumi; Masahiro Shimokawa; Go Ikeda; Risako Suzuki; Toshiaki Tsurui; Yutaro Kubota; Yosuke Sasaki; Mayumi Homma; Kiyoshi Yoshimura; Toshiko Yamochi; Shinichi Kobayashi; Takuya Tsunoda; Atsushi Horiike; Satoshi Wada
Cetirizine suppresses cancer-associated fibroblast-mediated fibrotic remodeling and epithelial–mesenchymal transition via histamine H1 receptor inverse agonism

西替利嗪通过组胺H1受体反向激动作用抑制癌相关成纤维细胞介导的纤维化重塑和上皮-间质转化

Breast Cancer Research
IF5.6
2026-04-260
OA
Aya Sasaki; Masahiro Hosonuma; Yuki Maruyama; Eiji Funayama; Hitoshi Toyoda; Toshiaki Tsurui; Kohei Tajima; Rie Nakashima; Yoshitaka Yamazaki; Akira Orimo; Tatsunori Oguchi; Kiyoshi Yoshimura; Atsuo Kuramasu
Elevated plasma IgG is associated with improved treatment response and survival in advanced non‑small cell lung cancer patients treated with anti‑PD‑1 therapy

血浆IgG升高与接受抗PD-1治疗晚期非小细胞肺癌患者的治疗反应改善及生存率提高相关

Scientific Reports
IF3.9
2026-04-200
OAAI
Ryotaro Ohkuma; Nobuyuki Onishi; Makoto Watanabe; Jian Jin; Hirotsugu Ariizumi; Masahiro Shimokawa; Go Ikeda; Tomoyuki Ishiguro; Risako Suzuki; Toshiaki Tsurui; Yutaro Kubota; Kiyoshi Yoshimura; Shinichi Kobayashi; Takuya Tsunoda; Atsushi Horiike; Satoshi Wada
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study

接受免疫检查点抑制剂治疗的患者醋摄入情况：食物频率问卷调查研究

Frontiers in Immunology
IF5.9
2025-12-110
OAAI
Hirotsugu Ariizumi; Miyuki Shimazui; Chisato Ogawa; Mika Kaneki; Nanaho Saito; Emiko Mura; Risako Suzuki; Toshiaki Tsurui; Nana Iriguchi; Tomoyuki Ishiguro; Yuya Hirasawa; Masahiro Shimokawa; Ryotaro Ohkuma; Yutaro Kubota; Atsushi Horiike; Satoshi Wada; Kiyoshi Yoshimura; Kouzou Murakami; Takuya Tsunoda
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity

次黄苷塑造PD-1阻断反应，并与双重PD-1/CTLA-4免疫疗法协同作用以增强抗肿瘤免疫。

cancer immunology immunotherapy
IF0
2025-08-190
OAAI
Yoichiro Narikawa; Atsuo Kuramasu; Masahiro Hosonuma; Masakazu Murayama; Eiji Funayama; Akiko Sasaki; Yuta Baba; Hitoshi Toyoda; Junya Isobe; Kohei Tajima; Rie Nakashima; Aya Sasaki; Yuki Maruyama; Yoshitaka Yamazaki; Midori Shida; Toshiaki Tsurui; Yuya Hirasawa; Hirotsugu Ariizumi; Tomoyuki Ishiguro; Risako Suzuki; Ryotaro Ohkuma; Yutaro Kubota; Takehiko Sambe; Mayumi Tsuji; Satoshi Wada; Atsushi Horiike; Shinichi Kobayashi; Takuya Tsunoda; Sei Kobayashi; Hitome Kobayashi; Tatsunori Oguchi; Toshikazu Shimane; Yuji Kiuchi; Kiyoshi Yoshimura
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit

Ki-67表达在程序性死亡蛋白-1抗体结合的CD8+ T细胞中作为临床获益的预测指标

DISCOVER ONCOLOGY
IF2.9
2025-03-180
OA
Tsurui, Toshiaki; Hosonuma, Masahiro; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Funayama, Eiji; Tajima, Kohei; Toyoda, Hitoshi; Isobe, Junya; Yamazaki, Yoshitaka; Baba, Yuta; Shida, Midori; Udaka, Yuko; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Kuramasu, Atsuo; Tsuji, Mayumi; Kiuchi, Yuji; Tsunoda, Takuya; Yoshimura, Kiyoshi
Association between the ABCC11 gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adults
MICROBIOLOGY SPECTRUM
IF3.8
2025-02-040
OAAI
Amari, Yasunobu; Hosonuma, Masahiro; Mizukami, Takuya; Isobe, Junya; Azetsu, Yuki; Funayama, Eiji; Maruyama, Yuki; Tsurui, Toshiaki; Tajima, Kohei; Sasaki, Aya; Yamazaki, Yoshitaka; Nakano, Ryota; Sano, Yutaka; Ishida, Atsushi; Nakanishi, Tatsuya; Mochizuki, Seiji; Yoshizawa, Yuri; Kumagai, Sumito; Yasuhara, Sakiko; Ryu, Kakei; Oguchi, Tatsunori; Kuramasu, Atsuo; Yoshimura, Kiyoshi; Sambe, Takehiko; Kobayashi, Sei; Uchida, Naoki
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors

免疫应激诱导的肿瘤突变负荷及新抗原表达在4T1乳腺癌细胞中的作用：长期存活于接受免疫检查点抑制剂治疗患者的一种潜在机制

CANCER GENOMICS & PROTEOMICS
IF2.6
2024-12-270
OA
Ishiguro, Tomoyuki; Takeda, Kazuyuki; Takayanagi, Daisuke; Mura, Emiko; Suzuki, Risako; Tsurui, Toshiaki; Iriguchi, Nana; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Izumizaki, Masahiko; Wada, Satoshi; Yoshimura, Kiyoshi; Hoffman, Robert m.; Tsunoda, Takuya
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients
FRONTIERS IN ONCOLOGY
IF3.3
2024-10-110
OAAI
Hirasawa, Yuya; Kubota, Yutaro; Mura, Emiko; Suzuki, Risako; Tsurui, Toshiaki; Iriguchi, Nana; Ishiguro, Tomoyuki; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Horiike, Atsushi; Wada, Satoshi; Yamashita, Takeshi; Ariyoshi, Tomotake; Goto, Satoru; Otsuka, Koji; Murakami, Masahiko; Kiuchi, Yuji; Yoshimura, Kiyoshi; Tsunoda, Takuya
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells

MHC I类多肽相关序列B脱落通过激活NKG2DLow T细胞调节胰腺肿瘤免疫

SCIENTIFIC REPORTS
IF3.9
2024-10-080
OAAI
Toyoda, Hitoshi; Kuramasu, Atsuo; Hosonuma, Masahiro; Murayama, Masakazu; Narikawa, Yoichiro; Isobe, Junya; Baba, Yuta; Tajima, Kohei; Funayama, Eiji; Shida, Midori; Maruyama, Yuki; Sasaki, Aya; Hirasawa, Yuya; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Kobayashi, Sei; Horiike, Atsushi; Hida, Noriko; Sambe, Takehiko; Nobe, Koji; Wada, Satoshi; Kobayashi, Hitome; Tsuji, Mayumi; Kobayashi, Shinichi; Tsunoda, Takuya; Kudo, Yoshifumi; Kiuchi, Yuji; Yoshimura, Kiyoshi
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

异丁酸增强anti-PD-1抗体的抗肿瘤作用

SCIENTIFIC REPORTS
IF3.9
2024-05-177
OAAI
Murayama, Masakazu; Hosonuma, Masahiro; Kuramasu, Atsuo; Kobayashi, Sei; Sasaki, Akiko; Baba, Yuta; Narikawa, Yoichiro; Toyoda, Hitoshi; Isobe, Junya; Funayama, Eiji; Tajima, Kohei; Sasaki, Aya; Maruyama, Yuki; Yamazaki, Yoshitaka; Shida, Midori; Hamada, Kazuyuki; Hirasawa, Yuya; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Kobayashi, Shinichi; Shimane, Toshikazu; Tsunoda, Takuya; Kobayashi, Hitome; Kiuchi, Yuji; Yoshimura, Kiyoshi
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Horiike, Atsushi; Wakui, Hiroshi; Sugawara, Shunichi; Minegishi, Yuji; Tasaka, Sadatomo; Kusumoto, Sojiro; Sakatani, Toshio; Suzuki, Hiroyuki; Hosomi, Yukio; Tambo, Yuichi; Shimokawa, Tsuneo; Ishida, Hiroo; Miyauchi, Eisaku; Naoki, Katsuhiko; Fukuhara, Tatsuro; Mura, Emiko; Tsurui, Toshiaki; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Manabe, Ryo; Shimokawa, Masahiro; Ohkuma, Ryotaro; Ariizumi, Hirotsugu; Kubota, Yutaro; Hamada, Kazuyuki; Takenoshita, Sachiko; Ryu, Kakei; Sambe, Takehiko; Inoue, Eisuke; Wada, Satoshi; Yoshimura, Kiyoshi; Sagara, Hironori; Kobayashi, Shinichi; Tsunoda, Takuya
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors

用荧光整合点评估PD-L1表达的新型定量免疫组织化学分析预测免疫检查点抑制剂治疗的癌症患者的疗效

FRONTIERS IN IMMUNOLOGY
IF5.9
2023-09-180
OAAI
Ohkuma, Ryotaro; Miura, Sakiko; Muto, Satoshi; Toyomasu, Yoshitaka; Fujimoto, Yuki; Ieguchi, Katsuaki; Onishi, Nobuyuki; Shimizu, Takashi; Watanabe, Makoto; Takayanagi, Daisuke; Goshima, Tsubasa; Horiike, Atsushi; Hamada, Kazuyuki; Ariizumi, Hirotsugu; Shimokawa, Masahiro; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Tsurui, Toshiaki; Mura, Emiko; Takenoshita, Sachiko; Numajiri, Kazuki; Okabe, Naoyuki; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Yajima, Toshiki; Ishida, Hideyuki; Suzuki, Hiroyuki; Yamochi, Toshiko; Kobayashi, Shinichi; Tsunoda, Takuya; Wada, Satoshi
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
FRONTIERS IN IMMUNOLOGY
IF5.9
2023-05-0322
OAAI
Hamada, Kazuyuki; Isobe, Junya; Hattori, Kouya; Hosonuma, Masahiro; Baba, Yuta; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Funayama, Eiji; Tajima, Kohei; Shida, Midori; Hirasawa, Yuya; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Kiuchi, Yuji; Kobayashi, Shinichi; Kuramasu, Atsuo; Horiike, Atsushi; Kim, Yun-Gi; Tsunoda, Takuya; Yoshimura, Kiyoshi

研究方向

暂未获取到该数据
K
Kiyoshi Yoshimura
H 指数:34论文数:220被引数:3,555
R
Ryotaro Ohkuma
H 指数:13论文数:60被引数:517
H
Hirotsugu Ariizumi
H 指数:15论文数:101被引数:636
R
Risako Suzuki
H 指数:8论文数:66被引数:260
Y
Yutaro Kubota
H 指数:24论文数:215被引数:3,141
Y
Yuya Hirasawa
H 指数:13论文数:94被引数:509
T
Tomoyuki Ishiguro
H 指数:11论文数:68被引数:423
A
Atsushi Horiike
H 指数:34论文数:207被引数:6,448
S
Satoshi Wada
H 指数:30论文数:131被引数:2,629
T
Takuya Tsunoda
H 指数:39论文数:290被引数:4,476